Concord Wealth Partners’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-627
Closed -$15.6K 974
2024
Q3
$15.6K Buy
+627
New +$18.6K ﹤0.01% 508
2023
Q4
Sell
-99
Closed -$3.67K 981
2023
Q3
$3.67K Hold
99
﹤0.01% 770
2023
Q2
$3.86K Hold
99
﹤0.01% 758
2023
Q1
$3.61K Hold
99
﹤0.01% 725
2022
Q4
$3.05K Buy
+99
New +$3.07K ﹤0.01% 862

Other funds holding RTO

Concord Wealth Partners's RTO Position: Q4 2024 in Review

Concord Wealth Partners sold out of Rentokil (RTO) in Q4 2024, closing a stake of 627 shares — an estimated $15.6K sold.

Concord Wealth Partners first reported a position in RTO in Q4 2022 and held it in 5 quarters. The position peaked at $15.6K in Q3 2024. 226 funds tracked by Wall St. Rank hold RTO as of Q4 2024.

  • Concord Wealth Partners reported no remaining Rentokil position as of Q4 2024 after selling out during the quarter.
  • Concord Wealth Partners sold 627 Rentokil shares in Q4 2024, an estimated $15.6K.
  • Concord Wealth Partners first reported a position in Rentokil in Q4 2022 and held it in 5 quarters.
  • Concord Wealth Partners's Rentokil position peaked at $15.6K in Q3 2024.
  • 226 funds tracked by Wall St. Rank held Rentokil as of Q4 2024.

Based on Concord Wealth Partners's 13F filing for Q4 2024, filed 24 Jan 2025.